• All
  • Advisory
  • Allergies
  • Blood
  • Blood Donations
  • Blood Testing
  • Pediatrics
  • Primary Care
  • Testosterone

Publish date: June 7, 2018 By Christopher Palmer  Hematology News The Food and Drug Administration has approved methoxy polyethylene glycol-epoetin beta (Mircera) for the treatment of dialysis-related anemia in pediatric patients aged 5-17 years with chronic kidney disease whose hemoglobin had been stabilized with an erythropoiesis-stimulating agent (ESA). The approval for this long-acting...